Systemic Inflammatory Markers Predict Upstaging in Early-Stage Endometrial Cancer: A FIGO 2023 Reclassification Study

No abstract is available for this paper.

• Publication year

  2025

• Venue

  SN Comprehensive Clinical Medicine

• Publication date

  2025-07-22

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s42399-025-01997-y
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer.

  2024influential reference
• External Validation of the New 2023 International Federation of Gynecology and Obstetrics Staging System in Endometrial Cancer Patients: 12-Year Experience from an European Society of Gynecological Oncology-Accredited Center

  2024influential reference
• Management of Patients Diagnosed with Endometrial Cancer: Comparison of Guidelines

  2023cited by this paper
• Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centres.

  2023influential reference
• FIGO staging of endometrial cancer: 2023

  2023cited by this paper
• Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma

  2023cited by this paper
• Analysis of levels and Clinical value of CA19-9, NLR and SIRI in patients with Pancreatic Cancer with different Clinical Features.

  2022cited by this paper
• Prognostic value of pretreatment systemic inflammatory markers in patients with stage I endometrial cancer

  2022cited by this paper
• Prognostic value of systemic inflammatory response markers in cervical cancer

  2022cited by this paper
• The Systemic Inflammation Response Index as an Independent Predictor of Survival in Breast Cancer Patients: A Retrospective Study

  2022cited by this paper
• The Associations of Two Novel Inflammation Indexes, SII and SIRI with the Risks for Cardiovascular Diseases and All-Cause Mortality: A Ten-Year Follow-Up Study in 85,154 Individuals

  2021cited by this paper
• Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer

  2021cited by this paper
• Systemic Inflammation Response Index as a Prognostic Marker in Cancer Patients: A Systematic Review and Meta-Analysis of 38 Cohorts

  2021cited by this paper
• Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification

  2021cited by this paper
• Pre-treatment inflammatory parameters predict survival from endometrial cancer: A prospective database analysis

  2021cited by this paper
• Preoperative neutrophil-to-lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratio as a prognostic factor in non-endometrioid endometrial cancer

  2021cited by this paper
• Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer

  2021cited by this paper
• 2020 WHO Classification of Female Genital Tumors

  2021cited by this paper
• Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer

  2021cited by this paper
• A Novel Prognostic Marker Systemic Inflammation Response Index (SIRI) for Operable Cervical Cancer Patients

  2020cited by this paper
• Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer

  2020cited by this paper
• Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).

  2019cited by this paper
• Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer Patients

  2019cited by this paper
• The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma

  2019cited by this paper
• Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis

  2019cited by this paper
• A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma

  2018cited by this paper
• Independent predictors of survival in endometrium cancer: platelet-to-lymphocyte ratio and platelet/neutrophil/monocyte-to-lymphocyte ratio

  2018cited by this paper
• Platelet to lymphocyte and neutrophil to lymphocyte ratio as predictive indices of endometrial carcinoma: Findings from a retrospective series of patients and meta-analysis.

  2018cited by this paper
• Can preoperative neutrophil to lymphocyte and platelet to lymphocyte ratios predict cervical stromal involvement in endometrioid endometrial adenocarcinoma?

  2017cited by this paper
• A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy

  2016cited by this paper
• [Clinical significance of the preoperative neutrophil lymphocyte ratio in the evaluation of the prognosis of laryngeal carcinoma].

  2016cited by this paper
• Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival

  2015cited by this paper
• Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a monoinstitutional study.

  2015cited by this paper
• Cancer-related inflammation and treatment effectiveness.

  2014cited by this paper
• Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms

  2013cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer.

  2011cited by this paper
• A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.

  2011cited by this paper
• Immunity, inflammation, and cancer.

  2010cited by this paper
• High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer

  2010cited by this paper
• Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio.

  2010cited by this paper
• Systemic Leukocyte Alterations Are Associated With Invasive Uterine Cervical Cancer

  2010cited by this paper
• Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

  2009cited by this paper
• Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma

  2008cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• Thrombocytosis as a prognostic factor in endometrial carcinoma.

  1998cited by this paper
• Prognostic

  1964cited by this paper

• Endometrioid Endometrium Kanserinde Lenfovasküler İnvazyon ve Lenf Nodu Metastazı İçin Sistemik İnflamatuvar ve Nutrisyonel İndekslerin Prognostik Değeri

  2026cites this paper